Skyscape Web Viewer : EBMG : Cardiovascular Disease and Vascular Diseases : Evidence summaries

View All
Rifabutin for Treating Pulmonary Tuberculosis
Riluzole for Patients with ALS
Rimonabant for Weight Reduction
Riociguat for Pulmonary Hypertension
Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women
Risk Assessment Tools for the Prevention of Pressure Ulcers
Risk Factors of Mastitis
Risk for Heparin-Induced Thrombocytopenia (HIT) with Either Low-Molecular-Weight Heparin (Lmwh) or Unfractionated Heparin (Ufh)
Risk of a Venous Thromboembolism during the Postpartum Period
Risk of Ischaemic Stroke in People with Migraine
Risk of Lactic Acidosis with Metformin in Type 2 Diabetes
Risk of Myocardial Infarction in Users of Third Generation Oral Contraceptives
Risk of Ovarian Cancer Associated with Ovulation Induction
Risk of Uterine Perforation in IUD Insertion
Risk of Venous Thromboembolism in Users of Combined Oral Contraceptives
Risk of Venous Thromboembolism with the Use of Oral Contraceptives
Risk of Venous Thrombosis in Users of 3rd Vs. 2nd Generation Combined Oral Contraceptives
Risperidone for Autism Spectrum Disorder
Risperidone for Psychosisinduced Aggression or Agitation (Rapid Tranquillisation)
Risperidone Versus Olanzapine for Schizophrenia
Risperidone Versus other Antipsychotics for People with Severe Mental Illness and Cooccurring Substance Misuse
Risperidone Versus Placebo for Schizophrenia
Risperidone Vs. other Atypical Antipsychotic Medication for Schizophrenia
Rituximab as Maintenance Therapy for Patients with Follicular Lymphoma
Rituximab for Rheumatoid Arthritis
Rivastigmine for Alzheimer's Disease
Rivastigmine for Vascular Cognitive Impairment
Robot Assistant for Laparoscopic Cholecystectomy
Rosiglitazone for Type 2 Diabetes Mellitus
Route of Hysterectomy for Benign Gynaecological Disease